Quantitative analysis of ligand effects on bioefficacy of nanoemulsion encapsulating depigmenting active

Colloids and Surfaces B: Biointerfaces

Volumn 122, Issue , 2014, Pages 390-395

  Atrux Tallau, Nicolas ^a   Lasselin, Juliette ^a   Han, Sang Hoon ^b   Delmas, Thomas ^c   Bibette, JérÔme ^a  

^a ESPCI   (France)

^b AmorePacific Corporation   (South Korea)

^c Capsum SAS Heliopolis Batiment C   (France)

Author keywords

Bioavailability; Licorice; Ligand; Melanogenesis inhibition; Nanoemulsion; Surface modification; Targeting

Indexed keywords

BIOCHEMISTRY; CHEMICAL MODIFICATION; DROPS; HYALURONIC ACID; MOLECULES; PLANTS (BOTANY); SURFACE TREATMENT;

BIOAVAILABILITY; LICORICE; MELANOGENESIS; NANOEMULSION; TARGETING;

LIGANDS;

CAPROYL HYALURONIC ACID; GLYCYRRHIZA EXTRACT; HYALURONIC ACID DERIVATIVE; ISOPILOSINE; LIGAND; MELANIN; PALMITOYL GLYCINE GLUTAMINE PROLINE ARGININE; PEPTIDE DERIVATIVE; POLYDATIN; UNCLASSIFIED DRUG; HYALURONIC ACID; PALMITOYL PEPTIDE; PEPTIDE; DRUG CARRIER; EMULSION;

ANIMAL CELL; ARTICLE; CELL INTERACTION; CONTROLLED STUDY; CYTOTOXICITY; DRUG EFFICACY; DRUG FORMULATION; ENCAPSULATION; IN VITRO STUDY; LIGHT SCATTERING; MELANOCYTE; MELANOGENESIS; MOUSE; NANOEMULSION; NONHUMAN; PHYSICAL CHEMISTRY; PRIORITY JOURNAL; QUANTITATIVE ANALYSIS; ZETA POTENTIAL; BIOAVAILABILITY; CELL ASSAY; CELL CONTACT; CHEMICAL MODIFICATION; GLYCYRRHIZA; NANOENCAPSULATION; PARTICLE SIZE; SURFACE PROPERTY; ANIMAL; DRUG SCREENING; EMULSION; NANOTECHNOLOGY; TUMOR CELL LINE;

ANIMALS; CELL LINE, TUMOR; DRUG CARRIERS; DRUG SCREENING ASSAYS, ANTITUMOR; EMULSIONS; LIGANDS; MICE; NANOTECHNOLOGY;

EID: 84905373214     PISSN: 09277765     EISSN: 18734367     Source Type: Journal    
DOI: 10.1016/j.colsurfb.2014.07.021     Document Type: Article

References (17)

1. Sperling R.A., Parak W.J. Surface modification, functionalization and bioconjugation of colloidal inorganic nanoparticles. Phil. Trans. A Math. Phys. Eng. Sci. 2010, 368:1333-1383.
2. Goutayer M., Dufort S., Josserand V., Royere A., Heinrich E., Vinet F., Bibette J., Coll J.-L., Texier I. Tumor targeting of functionalized lipid nanoparticles: assessment by in vivo fluorescence imaging. Eur. J. Pharm. Biopharm. 2010, 75:137-147.
3. Texier I., Goutayer M., Da Silva A., Guyon L., Djaker N., Josserand V., Neumann E., Bibette J., Vinet F. Cyanine-loaded lipid nanoparticles for improved in vivo fluorescence imaging. J. Biomed. Opt. 2009, 14:054005.
4. De Jong W.H., Borm P.J.A. Drug delivery and nanoparticles: applications and hazards. Int. J. Nanomed. 2008, 3:133-149.
5. Atrux-Tallau N., Delmas T., Han S.H., Kim J.W., Bibette J. Skin cell targeting with self-assembled ligand addressed nanoemulsion droplets. Int. J. Cosmet. Sci. 2013, 35:310-318.
6. Ganta S., Talekar M., Singh A., Coleman T.P., Amiji M.M. Nanoemulsions in translational research-opportunities and challenges in targeted cancer therapy. AAPS Pharm. Sci. Technol. 2014, 15:694-708.
7. Delmas T., Couffin A.-C., Bayle P.A., de Crecy F., Neumann E., Vinet F., Bardet M., Bibette J., Texier I. Preparation and characterization of highly stable lipid nanoparticles with amorphous core of tunable viscosity. J. Colloid Interf. Sci. 2011, 360:471-481.
8. Dutta R.C., Puri A., Anand N. Immunomodulatory potential of hydrophobic analogs of Rigin and their role in providing protection against Plasmodium berghei infection in mice. Int. Immunopharmacol. 2001, 1:843-855.
9. Choi K.Y., Saravanakumar G., Park J.H., Park K. Hyaluronic acid-based nanocarriers for intracellular targeting: interfacial interactions with proteins in cancer. Colloid Surf. B Biointerf. 2013, 99:82-94.
10. Misra S., Heldin P., Hascall V.C., Karamanos N.K., Skandalis S.S., Markwald R.R., Ghatak S. Hyaluronan-CD44 interactions as potential targets for cancer therapy. FEBS J. 2011, 278:1429-1443.
11. Jeong E.T., Jin M.H., Kim M.-S., Chang Y.H., Park S.G. Inhibition of melanogenesis by piceid isolated from Polygonum cuspidatum. Arch. Pharm. Res. 2010, 33:1331-1338.
12. Stability Testing of New Drug Substances and Products, in: EMeA (Ed.), ICH Topic Q 1 A (R2), European Medicines Agency, London, 2003.
13. Delmas T., Atrux-Tallau N., Goutayer M., Han S.H., Kim J.W., Bibette J. Nanoemulsions: Preparation, Stability and Application in Biosciences, Nanomaterials in Drug Delivery, Imaging, and Tissue Engineering 2012, 1-58. Wiley.
14. Garcia-Borron J.C., Sanchez-Laorden B.L., Jimenez-Cervantes C. Melanocortin-1 receptor structure and functional regulation. Pigment Cell Res. 2005, 18:393-410.
15. Kadekaro A.L., Kanto H., Kavanagh R., Abdel-Malek Z.A. Significance of the melanocortin 1 receptor in regulating human melanocyte pigmentation, proliferation, and survival. Ann. NY Acad. Sci. 2003, 994:359-365.
16. Lajis A.F.B., Hamid M., Ariff A.B. Depigmenting effect of Kojic acid esters in hyperpigmented B16F1 melanoma cells. J. Biomed. Biotechnol. 2012, 2012:952452.
17. Ahrens T., Assmann V., Fieber C., Termeer C., Herrlich P., Hofmann M., Simon J.C. CD44 is the principal mediator of hyaluronic-acid-induced melanoma cell proliferation. J. Invest. Dermatol. 2001, 116:93-101.